2.83
price up icon16.94%   0.41
after-market 시간 외 거래: 2.83
loading
전일 마감가:
$2.42
열려 있는:
$2.49
하루 거래량:
356.38K
Relative Volume:
1.12
시가총액:
$46.38M
수익:
-
순이익/손실:
$-94.11M
주가수익비율:
-0.4709
EPS:
-6.01
순현금흐름:
$-86.06M
1주 성능:
+27.48%
1개월 성능:
-12.38%
6개월 성능:
-52.12%
1년 성능:
-62.01%
1일 변동 폭
Value
$2.475
$2.83
1주일 범위
Value
$2.23
$2.83
52주 변동 폭
Value
$1.78
$10.14

Adverum Biotechnologies Inc Stock (ADVM) Company Profile

Name
명칭
Adverum Biotechnologies Inc
Name
전화
(650) 649-1004
Name
주소
100 CARDINAL WAY, REDWOOD CITY, CA
Name
직원
155
Name
트위터
@adverumbio
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
ADVM's Discussions on Twitter

ADVM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ADVM
Adverum Biotechnologies Inc
2.83 46.38M 0 -94.11M -86.06M -6.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-06-25 개시 Oppenheimer Outperform
2024-04-30 개시 H.C. Wainwright Buy
2022-07-07 업그레이드 Truist Hold → Buy
2021-07-23 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2021-05-03 다운그레이드 SVB Leerink Outperform → Mkt Perform
2021-04-29 다운그레이드 Chardan Capital Markets Buy → Neutral
2021-04-29 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2021-04-29 다운그레이드 Truist Buy → Hold
2020-12-16 개시 UBS Neutral
2020-11-12 업그레이드 Raymond James Underperform → Mkt Perform
2020-06-26 다운그레이드 Raymond James Mkt Perform → Underperform
2020-05-13 개시 RBC Capital Mkts Outperform
2020-05-05 업그레이드 SunTrust Hold → Buy
2020-04-28 개시 Goldman Buy
2020-03-16 개시 SVB Leerink Outperform
2020-02-10 업그레이드 Cantor Fitzgerald Neutral → Overweight
2020-02-10 업그레이드 Chardan Capital Markets Neutral → Buy
2019-10-15 재확인 Chardan Capital Markets Neutral
2019-09-13 재확인 Chardan Capital Markets Neutral
2019-06-14 재개 Raymond James Mkt Perform
2018-11-02 다운그레이드 Raymond James Outperform → Mkt Perform
2018-11-02 다운그레이드 SunTrust Buy → Hold
2018-09-21 개시 Cantor Fitzgerald Overweight
2018-08-30 개시 SunTrust Buy
2018-02-15 재개 Piper Jaffray Overweight
2017-10-12 개시 Raymond James Outperform
모두보기

Adverum Biotechnologies Inc 주식(ADVM)의 최신 뉴스

pulisher
Jun 06, 2025

Adverum Biotechnologies (NASDAQ:ADVM) versus Metagenomi (NASDAQ:MGX) Head-To-Head Analysis - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 05, 2025
pulisher
Jun 05, 2025

Adverum Awards 14,610 Shares in Stock Options and RSUs to Key New Hires - Stock Titan

Jun 05, 2025
pulisher
May 16, 2025

Adverum Biotechnologies Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Sees Price Target Adjustment by RBC Capital | ADVM Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Receives Continued Buy Rating from Chardan Capital | ADVM Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Price Target Reduced by RBC Capit - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Rating Reiterated at 'Buy' by HC Wainwright | ADVM Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

RBC Cuts Price Target on Adverum Biotechnologies to $4 From $5, Keeps Sector Perform, Speculative Risk - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies: Q1 Earnings Snapshot - CT Insider

May 15, 2025
pulisher
May 14, 2025

Adverum (ADVM) Projects Funding Through Late 2025 | ADVM Stock N - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline ... - Bluefield Daily Telegraph

May 14, 2025
pulisher
May 14, 2025

Revolutionary One-Time Gene Therapy Shows 3.5-Year Vision Protection in Wet AMD Patients - Stock Titan

May 14, 2025
pulisher
May 07, 2025

Adverum Biotechnologies Inc (ADVM)’s Market Momentum: Closing Strong at 3.23, Down -10.03 - DWinneX

May 07, 2025
pulisher
May 07, 2025

Adverum Biotechnologies’ SWOT analysis: gene therapy firm faces pivotal year - Investing.com Nigeria

May 07, 2025
pulisher
May 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc.ADVM - PR Newswire

May 06, 2025
pulisher
May 06, 2025

Adverum Biotechnologies' SWOT analysis: gene therapy firm faces pivotal year - Investing.com

May 06, 2025
pulisher
May 05, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum ... - Bluefield Daily Telegraph

May 05, 2025
pulisher
May 05, 2025

Adverum Biotechnologies Inc expected to post a loss of $1.94 a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 02, 2025

Adverum Biotechnologies Awards Strategic Stock Options Worth $108,000 to Expand Team - Stock Titan

May 02, 2025
pulisher
May 02, 2025

It makes sense and dollars to buy Adverum Biotechnologies Inc (ADVM) stock - Sete News

May 02, 2025
pulisher
Apr 30, 2025

Adverum Biotechnologies Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com

Apr 30, 2025
pulisher
Apr 28, 2025

Adverum Biotechnologies Inc [ADVM] Investment Guide: What You Need to Know - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Should investors be concerned about Adverum Biotechnologies Inc (ADVM)? - uspostnews.com

Apr 28, 2025
pulisher
Apr 28, 2025

Gaining Ground: Adverum Biotechnologies Inc (ADVM) Closes Lower at 2.91, Down -2.02 - DWinneX

Apr 28, 2025
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 24, 2025

Hedge Fund and Insider Trading News: Ken Griffin, Steve Cohen, Scott Bessent, Balyasny Asset Management, Bridgewater Associates, Starboard Value, Maverick Capital, Kodai Capital Management, Antara Capital, Adverum Biotechnologies Inc (ADVM), and - Insider Monkey

Apr 24, 2025
pulisher
Apr 24, 2025

Adverum Biotechnologies Insider Bought Shares Worth $1,048,950, According to a Recent SEC Filing - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

Adverum Biotechnologies Insider Buys 350,000 Shares - TradingView

Apr 24, 2025
pulisher
Apr 23, 2025

Adverum Biotechnologies Inc (ADVM) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Trading Day Triumph: Adverum Biotechnologies Inc (ADVM) Ends at 2.96, a 8.42 Surge/Plunge - DWinneX

Apr 23, 2025
pulisher
Apr 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Adverum Biotechnologies, Inc. (ADVM) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com

Apr 21, 2025
pulisher
Apr 21, 2025

Truist Removes $40 Price Target on Adverum Biotechnologies, Cites Share Volatility, Keeps Buy Rating - marketscreener.com

Apr 21, 2025
pulisher
Apr 20, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Adverum Biotechnologies, Inc. (ADVM) Investors to Inquire about Securities Investigation - markets.businessinsider.com

Apr 20, 2025
pulisher
Apr 18, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Adverum Biotechnologies, Inc. (ADVM) And Encourages Investors to Reach Out - markets.businessinsider.com

Apr 18, 2025
pulisher
Apr 18, 2025

Adverum Biotechnologies (NASDAQ:ADVM) Earns Buy Rating from HC Wainwright - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Adverum Biotechnologies, Inc. (ADVM) And Encourages Stockholders to Reach Out - markets.businessinsider.com

Apr 17, 2025
pulisher
Apr 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - GlobeNewswire Inc.

Apr 17, 2025
pulisher
Apr 17, 2025

Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

Apr 17, 2025
pulisher
Apr 16, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Adverum Biotechnologies, Inc. (ADVM) And Encourages Stockholders to Connect - markets.businessinsider.com

Apr 16, 2025
pulisher
Apr 16, 2025

RBC Cuts Price Target on Adverum Biotechnologies to $5 From $10, Keeps Sector Perform, Speculative Risk - marketscreener.com

Apr 16, 2025
pulisher
Apr 15, 2025

Adverum Biotechnologies Reports 2024 Financial Results and Pipeline Progress - TipRanks

Apr 15, 2025

Adverum Biotechnologies Inc (ADVM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
자본화:     |  볼륨(24시간):